Loading…
Reported covered position: Director of the Office of Legislation, CMS; Counsel, House Energy and Commerce Committee; Counsel, Senate Committee on Homeland Security and Government Affairs; Counsel, House Oversight and Government Reform Committee
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: ARDENT HEALTH SERVICES · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Medicare coverage and reimbursement issues Medicaid coverage issues Medicaid provider tax State directed payments P.L. 119-21 (H.R. 1): One Big Beautiful Bill implementation
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CENTENE CORPORATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
CENCORA, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · third_quarter · Q3
Drug Shortages; supply chain resiliency; PAHPA Reauthorization; Drug Supply Chain Security Act (DSCSA) Implementation, SUPPORT Act Reauthorization, Appropriations bills (FDA, Labor, HHS). Issues related to vertical integration
Recognizing pharmacists as providers within Medicare; The Equitable Introduction of Community Access to Pharmacist Services Act Medicare reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
| LILLY USA, LLC |
| 28 |
| 2019–2026 |
| WALGREEN CO | 27 | 2019–2025 |
| ARDENT HEALTH SERVICES | 26 | 2020–2026 |
| MODERNA US INC. | 25 | 2021–2026 |
| NATIONAL MENTOR HOLDINGS, INC. | 25 | 2020–2026 |
| THE FEDERATION OF STATE MEDICAL BOARDS | 25 | 2019–2025 |
| EMERGENCY NURSES ASSOCIATION | 24 | 2021–2026 |
| SPARK THERAPEUTICS, INC. | 23 | 2019–2025 |
| INTERNATIONAL HEARING SOCIETY | 22 | 2019–2024 |
| TAPESTRYHEALTH | 20 | 2022–2026 |
| TEXAS CHILDREN'S HOSPITAL | 20 | 2022–2026 |
| ANTHEM, INC. | 16 | 2019–2022 |
| CONSENSUS CLOUD SOLUTIONS | 16 | 2023–2026 |
| NMAC (ON BEHALF OF THE HIV/STD PARTNERSHIP) | 16 | 2019–2022 |
| SOLVD HEALTH | 16 | 2023–2026 |
| Cepheid | 15 | 2021–2024 |
| FERRING PHARMACEUTICALS, INC. | 15 | 2023–2026 |
| NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS (N.A.C.H.)-CHA | 15 | 2023–2026 |
| TEXTILE RENTAL SERVICES ASSOCIATION | 15 | 2020–2023 |
| CENCORA, INC. | 14 | 2023–2026 |
| SOUTHEAST ALASKA REGIONAL HEALTH CONSORTIUM | 14 | 2022–2024 |
| UNIVERSITY OF COLORADO HEALTH | 14 | 2023–2026 |
| CAREDX, INC. | 13 | 2019–2023 |
| HARMONY FOODS, LLC D/B/A SCN BESTCO, FORMALLY REPORTED AS, SANTA CRUZ HEALTHCARE | 13 | 2020–2024 |
| RELX INC. | 13 | 2023–2026 |
| BAXTER HEALTHCARE CORPORATION | 11 | 2019–2022 |
| GLEIF AMERICAS | 9 | 2021–2023 |
| WECONNECT HEALTH MANAGEMENT | 9 | 2021–2022 |
| Enovis Corporation | 8 | 2022–2024 |
| J2 GLOBAL COMMUNICATIONS INC | 8 | 2019–2020 |
| MONOGRAM HEALTH | 8 | 2021–2023 |
| ROMARK GLOBAL PHARMA, LLC | 8 | 2022–2023 |
| ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS | 8 | 2025–2026 |
| TENET BUSINESS SERVICES CORPORATION | 8 | 2020–2021 |
| ADVANCING MENTAL HEALTH FOR MILITARY FAMILIES, LLC | 7 | 2025–2026 |
| AMPLIO | 7 | 2021–2022 |
| BECKMAN COULTER DIAGNOSTICS | 7 | 2020–2021 |
| HARMONY BIOSCIENCES | 7 | 2019–2024 |
| THE JEWISH FEDERATIONS OF NORTH AMERICA | 7 | 2025–2026 |
| COMPASS CONNECTIONS | 6 | 2023–2024 |
| COMPASS UNITED | 6 | 2023–2024 |
| ENVOY MEDICAL CORPORATION | 6 | 2023–2024 |
| HEMOCUE AMERICA | 6 | 2021–2022 |
| PARTICLE HEALTH | 6 | 2024–2025 |
| STATE COLLECTION SERVICE, INC. | 6 | 2025–2026 |
| ZOTEC PARTNERS | 6 | 2021–2022 |
| ADVAMED | 5 | 2020–2021 |
| AMGEN USA, INC. | 5 | 2019–2020 |
| DEACON HEALTH | 5 | 2025–2026 |
| ENVISION HEALTHCARE | 5 | 2020–2021 |
| ESO SOLUTIONS, INC. | 5 | 2025–2026 |
| THE INTERNATIONAL ASSOCIATION OF LIONS CLUBS | 5 | 2025–2026 |
| AIPHARMA GLOBAL HOLDINGS LIMITED | 4 | 2021–2022 |
| EDERA L3C | 4 | 2026 |
| GRINDR LLC | 4 | 2025–2026 |
| KYVERNA THERAPEUTICS, INC. | 4 | 2026 |
| MARSHFIELD CLINIC HEALTH SYSTEM | 4 | 2020 |
| MUSCLESOUND, INC. | 4 | 2025–2026 |
| SKILLFUL COMMUNICATIONS, INC. DBA BIG INTERVIEW | 4 | 2025–2026 |
| ADITXT INC. | 3 | 2021–2022 |
| ASANA VOICES, FORMERLY REPORTED AS, ASANA VOICES, LLC | 3 | 2026 |
| ATRIUM HEALTH | 3 | 2021 |
| CINNAMON HEALTH | 3 | 2025 |
| GLYTEC, LLC | 3 | 2025 |
| LEARNED HAND | 3 | 2025 |
| NORTHERN COMPASS GROUP LLC OBO PETERSBURG MEDICAL CENTER | 3 | 2023 |
| PATHEMAGX | 3 | 2021 |
| PURDUE PHARMA L.P. | 3 | 2022 |
| SNAP DIAGNOSTICS, LLP | 3 | 2026 |
| VENUESCREEN | 3 | 2020 |
| AKTIV PHARMA GROUP | 2 | 2021 |
| AMERICAN UNITY FUND (PANDEMIC PREVENTION) | 2 | 2022 |
| BECTON, DICKINSON AND COMPANY | 2 | 2026 |
| CLEAR | 2 | 2025–2026 |
| CLEVELAND CLINIC FOUNDATION | 2 | 2020 |
| PIERRE FABRE PHARMACEUTICALS, INC. | 2 | 2025–2026 |
| PIM BRANDS | 2 | 2025 |
| ROMER INSTITUTE OF STROKE AND NEUROLOGY (RISN) | 2 | 2026 |
| TOLMAR, INC. | 2 | 2026 |
| EXHIBITIONS & CONFERENCES ALLIANCE | 1 | 2020 |
| GRANICUS, LLC | 1 | 2025 |
| KABAFUSION | 1 | 2020 |
| PURESTAR GROUP | 1 | 2020 |
Issues related to ACA, Medicare Advantage, and Medicaid Issues related to Artificial Intelligence in healthcare P.L. 119-21 (H.R. 1): One Big Beautiful Bill implementation Healthcare premium tax credits
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CENTENE CORPORATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to ACA, Medicare Advantage, and Medicaid Issues related to Artificial Intelligence in healthcare P.L. 119-21 (H.R. 1): One Big Beautiful Bill implementation Healthcare premium tax credits Pharmacy contracts for long term care (LTC)
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: ARDENT HEALTH SERVICES · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Medicare coverage and reimbursement issues Medicaid coverage issues Medicaid provider tax State directed payments Enhanced premium tax credit P.L. 119-21 (H.R. 1): One Big Beautiful Bill implementation
National Plan for Epilepsy Act
Client: VALLEY CHILDREN'S HEALTHCARE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to Children's Hospitals Graduate Medical Education Payment (CHGME) program Issues related to children's mental health Medicaid coverage and reimbursement issues Pediatric workforce funding H.R. 1189 The National Plan for Epilepsy H.R. 2106 The Expanding Medical Education Act H.R. 4849 Protecting Health Care and Lowering Costs Act of 2025
Maintaining Investments in New Innovation Act
Client: NOVARTIS · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to cell and gene therapy and radioligand therapies Pharmaceutical pricing Issues related to the development of therapies for rare diseases 340B Drug Discount Program Supply chain issues affecting pharmaceutical products Implementation of the Inflation reduction Act Pharmaceutical innovation PBM policy issues HR 1672 The Maintaining Investments in New Innovations (MINI) Act Intellectual property Issues Tariff issues affecting the pharmaceutical industry EPIC Act Most Favored Nation (MFN) policy
Maintaining Investments in New Innovation Act
Client: NOVARTIS · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to cell and gene therapy and radioligand therapies Pharmaceutical pricing Issues related to the development of therapies for rare diseases 340B Drug Discount Program Supply chain issues affecting pharmaceutical products Implementation of the Inflation reduction Act Pharmaceutical innovation PBM policy issues HR 1672 The Maintaining Investments in New Innovations (MINI) Act Intellectual property Issues Tariff issues affecting the pharmaceutical industry EPIC Act Most Favored Nation (MFN) policy Tribal health issues
Maintaining Investments in New Innovation Act
Client: NOVARTIS · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to cell and gene therapy and radioligand therapies Pharmaceutical pricing Issues related to the development of therapies for rare diseases 340B Drug Discount Program Supply chain issues affecting pharmaceutical products Implementation of the Inflation reduction Act Pharmaceutical innovation PBM policy issues HR 1672 The Maintaining Investments in New Innovations (MINI) Act Intellectual property Issues Tariff issues affecting the pharmaceutical industry EPIC Act Most Favored Nation (MFN) policy
Tyler’s Law
Client: EMERGENCY NURSES ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
S. 266 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act Healthcare work shortages S.1600 Save Healthcare Workers Act S. 921 Tyler's Law H.R. 2004 Tyler's Law
Tyler’s Law
Client: EMERGENCY NURSES ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
S. 266 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act Healthcare work shortages S.1600 Save Healthcare Workers Act S. 921 Tyler's Law H.R. 2004 Tyler's Law
Tyler’s Law
Client: EMERGENCY NURSES ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
S. 266 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act Healthcare work shortages S.1600 Save Healthcare Workers Act S. 921 Tyler's Law H.R. 2004 Tyler's Law
Expanding Medical Education Act
Client: VALLEY CHILDREN'S HEALTHCARE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to Children's Hospitals Graduate Medical Education Payment (CHGME) program Issues related to children's mental health Medicaid coverage and reimbursement issues Pediatric workforce funding H.R. 1189 The National Plan for Epilepsy H.R. 2106 The Expanding Medical Education Act H.R. 4849 Protecting Health Care and Lowering Costs Act of 2025
Expanding Medical Education Act
Client: VALLEY CHILDREN'S HEALTHCARE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to Children's Hospitals Graduate Medical Education Payment (CHGME) program Issues related to children's mental health Medicaid coverage and reimbursement issues Pediatric workforce funding FEMA Funding Delays H.R. 2106 The Expanding Medical Education Act H.R. 4849 Protecting Health Care and Lowering Costs Act of 2025
Recognizing Community Organizations for Veteran Engagement and Recovery Act
Client: ADVANCING MENTAL HEALTH FOR MILITARY FAMILIES, LLC · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Advocating for increased access to outpatient mental health care services provided in community settings for veterans, active duty servicemembers, and their families who are in need of treatment for mental health issues (depression, anxiety, and PTSD). Specifically, advocating for enactment of H.R. 2283, the RECOVER Act, which would permit VA to contract with outpatient community providers to deliver evidence-based mental health treatment.
Recognizing Community Organizations for Veteran Engagement and Recovery Act
Client: ADVANCING MENTAL HEALTH FOR MILITARY FAMILIES, LLC · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Advocating for increased access to outpatient mental health care services provided in community settings for veterans, active duty servicemembers, and their families who are in need of treatment for mental health issues (depression, anxiety, and PTSD). Specifically, advocating for enactment of H.R. 2283, the RECOVER Act, which would permit VA to contract with outpatient community providers to deliver evidence-based mental health treatment.
Recognizing Community Organizations for Veteran Engagement and Recovery Act
Client: ADVANCING MENTAL HEALTH FOR MILITARY FAMILIES, LLC · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Advocating for increased access to outpatient mental health care services provided in community settings for veterans, active duty servicemembers, and their families who are in need of treatment for mental health issues (depression, anxiety, and PTSD). Specifically, advocating for enactment of H.R. 2283, the RECOVER Act, which would permit VA to contract with outpatient community providers to deliver evidence-based mental health treatment.
Early Detection of Vision Impairments for Children Act of 2025
Client: THE INTERNATIONAL ASSOCIATION OF LIONS CLUBS · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Safeguarding U.S. foreign aid for global health initiatives, promoting public health legislation and campaigns. H.R.3674 Global Alzheimers Initiative Now Act H.R.2527 Early Detection of Vision Impairments for Children Issues related to resolution on volunteer service
Rural healthcare coverage and reimbursement Student loan repayment Competition issues Healthcare workforce and staffing issues Medicare and Medicaid reimbursement Medicaid provider tax State directed payments Rural Health Transformation Fund H.R.3108/ S.1535 RPM Access Act
Global Alzheimer’s Initiative Now Act
Client: THE INTERNATIONAL ASSOCIATION OF LIONS CLUBS · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Safeguarding U.S. foreign aid for global health initiatives, promoting public health legislation and campaigns. H.R.3674 Global Alzheimers Initiative Now Act H.R.2527 Early Detection of Vision Impairments for Children Issues related to resolution on volunteer service
Protecting Health Care and Lowering Costs Act of 2025
Client: VALLEY CHILDREN'S HEALTHCARE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to Children's Hospitals Graduate Medical Education Payment (CHGME) program Issues related to children's mental health Medicaid coverage and reimbursement issues Pediatric workforce funding FEMA Funding Delays H.R. 2106 The Expanding Medical Education Act H.R. 4849 Protecting Health Care and Lowering Costs Act of 2025
Protecting Health Care and Lowering Costs Act of 2025
Client: VALLEY CHILDREN'S HEALTHCARE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to Children's Hospitals Graduate Medical Education Payment (CHGME) program Issues related to children's mental health Medicaid coverage and reimbursement issues Pediatric workforce funding H.R. 1189 The National Plan for Epilepsy H.R. 2106 The Expanding Medical Education Act H.R. 4849 Protecting Health Care and Lowering Costs Act of 2025
Rural Patient Monitoring (RPM) Access Act
Client: LIFEPOINT HEALTH · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Rural healthcare coverage and reimbursement Student loan repayment Competition issues Healthcare workforce and staffing issues Medicare and Medicaid reimbursement Medicaid provider tax State directed payments Rural Health Transformation Fund H.R.3108/ S.1535 RPM Access Act
Save Healthcare Workers Act
Client: EMERGENCY NURSES ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
S. 266 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act Healthcare work shortages S.1600 Save Healthcare Workers Act S. 921 Tyler's Law H.R. 2004 Tyler's Law
Save Healthcare Workers Act
Client: EMERGENCY NURSES ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
S. 266 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act Healthcare work shortages S.1600 Save Healthcare Workers Act S. 921 Tyler's Law H.R. 2004 Tyler's Law
Save Healthcare Workers Act
Client: EMERGENCY NURSES ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
S. 266 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act Healthcare work shortages S.1600 Save Healthcare Workers Act S. 921 Tyler's Law H.R. 2004 Tyler's Law
Patients Deserve Price Tags Act
Client: UNIVERSITY OF COLORADO HEALTH · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to Medicare coverage and reimbursement Issues related to hospital reforms and price transparency Medicaid provider tax issue State directed payments S.2355 - Patients Deserve Price Tags Act
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: EMERGENCY NURSES ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
S. 266 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act Healthcare work shortages S.1600 Save Healthcare Workers Act S. 921 Tyler's Law H.R. 2004 Tyler's Law
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: EMERGENCY NURSES ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
S. 266 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act Healthcare work shortages S.1600 Save Healthcare Workers Act S. 921 Tyler's Law H.R. 2004 Tyler's Law
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: EMERGENCY NURSES ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
S. 266 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act Healthcare work shortages S.1600 Save Healthcare Workers Act S. 921 Tyler's Law H.R. 2004 Tyler's Law
Stroke Act
Client: ROMER INSTITUTE OF STROKE AND NEUROLOGY (RISN) · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Strategy to establish a CMMI pilot program related to stroke recovery and advocacy around the Stroke Act (S. 5260).
Stroke Act
Client: ROMER INSTITUTE OF STROKE AND NEUROLOGY (RISN) · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Strategy to establish a CMMI pilot program related to stroke recovery and advocacy around the Stroke Act (S. 5260).
Advancing legislation on cardiovascular health and related issues. S.5469 HEART Foundation Act
S. 266 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act Healthcare work shortages S.1600 Save Healthcare Workers Act S. 921 Tyler's Law H.R. 2004 Tyler's Law
S. 266 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act Healthcare work shortages S.1600 Save Healthcare Workers Act S. 921 Tyler's Law H.R. 2004 Tyler's Law
S. 266 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act Healthcare work shortages S.1600 Save Healthcare Workers Act S. 921 Tyler's Law H.R. 2004 Tyler's Law
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CENTENE CORPORATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to ACA, Medicare Advantage, and Medicaid General mental health policy Issues related to Artificial Intelligence in healthcare H.R.1 implementation Healthcare premium tax credits
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: ARDENT HEALTH SERVICES · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Medicare coverage and reimbursement issues Medicaid coverage issues Medicaid provider tax State directed payments Enhanced premium tax credit P.L. 119-21 (H.R. 1): One Big Beautiful Bill implementation
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: ARDENT HEALTH SERVICES · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Medicare coverage and reimbursement issues Medicaid coverage issues Medicaid provider tax State directed payments enhanced premium tax credit H.R.1 implementation
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CENTENE CORPORATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to ACA, Medicare Advantage, and Medicaid General mental health policy Issues related to Artificial Intelligence in healthcare H.R.1 One Big Beautiful Bill
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: ARDENT HEALTH SERVICES · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Medicare coverage and reimbursement issues Medicaid coverage issues Medicaid provider tax State directed payments enhanced premium tax credit H.R.1 One Big Beautiful Bill
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CENTENE CORPORATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to ACA, Medicare Advantage, and Medicaid Issues related to Artificial Intelligence in healthcare P.L. 119-21 (H.R. 1): One Big Beautiful Bill implementation Healthcare premium tax credits
National Plan for Epilepsy Act
Client: VALLEY CHILDREN'S HEALTHCARE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to Children's Hospitals Graduate Medical Education Payment (CHGME) program Issues related to children's mental health Medicaid coverage and reimbursement issues Pediatric workforce funding Funding for hospital microgrid H.R. 1189 The National Plan for Epilepsy H.R. 2106 The Expanding Medical Education Act H.R. 4849 Protecting Health Care and Lowering Costs Act of 2025 H.R. 2002 MATCH IT Act H.R.5355 - Ian Kalvinskas Pediatric Liver Cancer Early Detection and Screening Act
National Plan for Epilepsy Act
Client: VALLEY CHILDREN'S HEALTHCARE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to Children's Hospitals Graduate Medical Education Payment (CHGME) program Issues related to children's mental health Medicaid coverage and reimbursement issues Pediatric workforce funding Funding for hospital microgrid H.R. 1189 The National Plan for Epilepsy H.R. 2106 The Expanding Medical Education Act H.R. 4849 Protecting Health Care and Lowering Costs Act of 2025
Maintaining Investments in New Innovation Act
Client: NOVARTIS · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to cell and gene therapy and radioligand therapies Pharmaceutical pricing Issues related to the development of therapies for rare diseases 340B Drug Discount Program Supply chain issues affecting pharmaceutical products Implementation of the Inflation reduction Act Pharmaceutical innovation PBM policy issues HR 1672 The Maintaining Investments in New Innovations (MINI) Act Intellectual property Issues Tariff issues affecting the pharmaceutical industry EPIC Act
Maintaining Investments in New Innovation Act
Client: NOVARTIS · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to cell and gene therapy and radioligand therapies Pharmaceutical pricing Issues related to the development of therapies for rare diseases 340B Drug Discount Program Supply chain issues affecting pharmaceutical products Implementation of the Inflation reduction Act Pharmaceutical innovation PBM policy issues HR 1672 The Maintaining Investments in New Innovations (MINI) Act Intellectual property Issues
Maintaining Investments in New Innovation Act
Client: NOVARTIS · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to cell and gene therapy and radioligand therapies Pharmaceutical pricing Issues related to the development of therapies for rare diseases 340B Drug Discount Program Supply chain issues affecting pharmaceutical products Implementation of the Inflation reduction Act Pharmaceutical innovation PBM policy issues HR 1672 The Maintaining Investments in New Innovations (MINI) Act Intellectual property Issues Tariff issues affecting the pharmaceutical industry EPIC Act Most Favored Nation (MFN) policy
Maintaining Investments in New Innovation Act
Client: NOVARTIS · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to cell and gene therapy and radioligand therapies Pharmaceutical pricing Issues related to the development of therapies for rare diseases 340B Drug Discount Program Supply chain issues affecting pharmaceutical products Implementation of the Inflation reduction Act Pharmaceutical innovation PBM policy issues HR 1672 The Maintaining Investments in New Innovations (MINI) Act Intellectual property Issues Tariff issues affecting the pharmaceutical industry EPIC Act Most Favored Nation (MFN) policy
MATCH IT Act of 2025
Client: VALLEY CHILDREN'S HEALTHCARE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to Children's Hospitals Graduate Medical Education Payment (CHGME) program Issues related to children's mental health Medicaid coverage and reimbursement issues Pediatric workforce funding Funding for hospital microgrid H.R. 1189 The National Plan for Epilepsy H.R. 2106 The Expanding Medical Education Act H.R. 4849 Protecting Health Care and Lowering Costs Act of 2025 H.R. 2002 MATCH IT Act H.R.5355 - Ian Kalvinskas Pediatric Liver Cancer Early Detection and Screening Act
Tyler’s Law
Client: EMERGENCY NURSES ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
S. 266 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act Healthcare work shortages S.1600 Save Healthcare Workers Act S. 921 Tyler's Law H.R. 2004 Tyler's Law
Expanding Medical Education Act
Client: VALLEY CHILDREN'S HEALTHCARE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to Children's Hospitals Graduate Medical Education Payment (CHGME) program Issues related to children's mental health Medicaid coverage and reimbursement issues Pediatric workforce funding Funding for hospital microgrid H.R. 1189 The National Plan for Epilepsy H.R. 2106 The Expanding Medical Education Act H.R. 4849 Protecting Health Care and Lowering Costs Act of 2025
Expanding Medical Education Act
Client: VALLEY CHILDREN'S HEALTHCARE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to Children's Hospitals Graduate Medical Education Payment (CHGME) program Issues related to children's mental health Medicaid coverage and reimbursement issues Pediatric workforce funding Funding for hospital microgrid H.R. 1189 The National Plan for Epilepsy H.R. 2106 The Expanding Medical Education Act H.R. 4849 Protecting Health Care and Lowering Costs Act of 2025 H.R. 2002 MATCH IT Act H.R.5355 - Ian Kalvinskas Pediatric Liver Cancer Early Detection and Screening Act
Recognizing Community Organizations for Veteran Engagement and Recovery Act
Client: ADVANCING MENTAL HEALTH FOR MILITARY FAMILIES, LLC · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Advocating for increased access to outpatient mental health care services provided in community settings for veterans, active duty servicemembers, and their families who are in need of treatment for mental health issues (depression, anxiety, and PTSD). Specifically, advocating for enactment of H.R. 2283, the RECOVER Act, which would permit VA to contract with outpatient community providers to deliver evidence-based mental health treatment.
Recognizing Community Organizations for Veteran Engagement and Recovery Act
Client: ADVANCING MENTAL HEALTH FOR MILITARY FAMILIES, LLC · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Advocating for increased access to outpatient mental health care services provided in community settings for veterans, active duty servicemembers, and their families who are in need of treatment for mental health issues (depression, anxiety, and PTSD). Specifically, advocating for enactment of H.R. 2283, the RECOVER Act, which would permit VA to contract with outpatient community providers to deliver evidence-based mental health treatment.
Recognizing Community Organizations for Veteran Engagement and Recovery Act
Client: ADVANCING MENTAL HEALTH FOR MILITARY FAMILIES, LLC · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Advocating for increased access to outpatient mental health care services provided in community settings for veterans, active duty servicemembers, and their families who are in need of treatment for mental health issues (depression, anxiety, and PTSD). Specifically, advocating for enactment of H.R. 2283, the RECOVER Act, which would permit VA to contract with outpatient community providers to deliver evidence-based mental health treatment.
Recognizing Community Organizations for Veteran Engagement and Recovery Act
Client: ADVANCING MENTAL HEALTH FOR MILITARY FAMILIES, LLC · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Advocating for increased access to outpatient mental health care services provided in community settings for veterans, active duty servicemembers, and their families who are in need of treatment for mental health issues (depression, anxiety, and PTSD). Specifically, advocating for enactment of H.R. 2283, the RECOVER Act, which would permit VA to contract with outpatient community providers to deliver evidence-based mental health treatment.
Recognizing Community Organizations for Veteran Engagement and Recovery Act
Client: ADVANCING MENTAL HEALTH FOR MILITARY FAMILIES, LLC · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Advocating for increased access to outpatient mental health care services provided in community settings for veterans, active duty servicemembers, and their families who are in need of treatment for mental health issues (depression, anxiety, and PTSD). Specifically, advocating for enactment of H.R. 2283, the RECOVER Act, which would permit VA to contract with outpatient community providers to deliver evidence-based mental health treatment.
SHARE Act of 2026
Client: THE FEDERATION OF STATE MEDICAL BOARDS · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to the licensure of physicians, telemedicine, and state medical boards Issues related to substance abuse H.R. 2332/S.1101 SHARE ACT
SHARE Act of 2026
Client: THE FEDERATION OF STATE MEDICAL BOARDS · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to the licensure of physicians, telemedicine, and state medical boards Issues related to substance abuse H.R. 2332/S.1101 SHARE ACT
Protecting Health Care and Lowering Costs Act of 2025
Client: VALLEY CHILDREN'S HEALTHCARE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to Children's Hospitals Graduate Medical Education Payment (CHGME) program Issues related to children's mental health Medicaid coverage and reimbursement issues Pediatric workforce funding Funding for hospital microgrid H.R. 1189 The National Plan for Epilepsy H.R. 2106 The Expanding Medical Education Act H.R. 4849 Protecting Health Care and Lowering Costs Act of 2025
Protecting Health Care and Lowering Costs Act of 2025
Client: VALLEY CHILDREN'S HEALTHCARE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to Children's Hospitals Graduate Medical Education Payment (CHGME) program Issues related to children's mental health Medicaid coverage and reimbursement issues Pediatric workforce funding Funding for hospital microgrid H.R. 1189 The National Plan for Epilepsy H.R. 2106 The Expanding Medical Education Act H.R. 4849 Protecting Health Care and Lowering Costs Act of 2025 H.R. 2002 MATCH IT Act H.R.5355 - Ian Kalvinskas Pediatric Liver Cancer Early Detection and Screening Act
Ian Kalvinskas Pediatric Liver Cancer Early Detection and Screening Act
Client: VALLEY CHILDREN'S HEALTHCARE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to Children's Hospitals Graduate Medical Education Payment (CHGME) program Issues related to children's mental health Medicaid coverage and reimbursement issues Pediatric workforce funding Funding for hospital microgrid H.R. 1189 The National Plan for Epilepsy H.R. 2106 The Expanding Medical Education Act H.R. 4849 Protecting Health Care and Lowering Costs Act of 2025 H.R. 2002 MATCH IT Act H.R.5355 - Ian Kalvinskas Pediatric Liver Cancer Early Detection and Screening Act
SHARE Act of 2025
Client: THE FEDERATION OF STATE MEDICAL BOARDS · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to the licensure of physicians, telemedicine, and state medical boards Issues related to substance abuse H.R. 2332/S.1101 SHARE ACT
SHARE Act of 2025
Client: THE FEDERATION OF STATE MEDICAL BOARDS · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to the licensure of physicians, telemedicine, and state medical boards Issues related to substance abuse H.R. 2332/S.1101 SHARE ACT
Save Healthcare Workers Act
Client: EMERGENCY NURSES ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
S. 266 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act Healthcare work shortages S.1600 Save Healthcare Workers Act S. 921 Tyler's Law
Save Healthcare Workers Act
Client: EMERGENCY NURSES ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
S. 266 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act Healthcare work shortages S.1600 Save Healthcare Workers Act S. 921 Tyler's Law
Save Healthcare Workers Act
Client: EMERGENCY NURSES ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
S. 266 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act Healthcare work shortages S.1600 Save Healthcare Workers Act S. 921 Tyler's Law H.R. 2004 Tyler's Law
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: EMERGENCY NURSES ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
S. 266 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act Healthcare work shortages S.1600 Save Healthcare Workers Act S. 921 Tyler's Law
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: EMERGENCY NURSES ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
S. 266 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act Healthcare work shortages S.1600 Save Healthcare Workers Act S. 921 Tyler's Law
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: EMERGENCY NURSES ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
S. 266 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act Healthcare work shortages save Healthcare Workers Act S. 921 Tyler's Law
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
Client: EMERGENCY NURSES ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
S. 266 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act Healthcare work shortages S.1600 Save Healthcare Workers Act S. 921 Tyler's Law H.R. 2004 Tyler's Law
S. 266 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act Healthcare work shortages S.1600 Save Healthcare Workers Act S. 921 Tyler's Law
S. 266 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act Healthcare work shortages S.1600 Save Healthcare Workers Act S. 921 Tyler's Law H.R. 2004 Tyler's Law
S. 266 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act Healthcare work shortages S.1600 Save Healthcare Workers Act S. 921 Tyler's Law
S. 266 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act Healthcare work shortages save Healthcare Workers Act S. 921 Tyler's Law
SHARE Act
Client: THE FEDERATION OF STATE MEDICAL BOARDS · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to the licensure of physicians, telemedicine, and state medical boards Issues related to substance abuse SHARE ACT (HR 1310)
SHARE Act
Client: THE FEDERATION OF STATE MEDICAL BOARDS · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to the licensure of physicians, telemedicine, and state medical boards Issues related to substance abuse SHARE ACT (HR 1310)
SHARE Act
Client: THE FEDERATION OF STATE MEDICAL BOARDS · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to the licensure of physicians, telemedicine, and state medical boards Issues related to substance abuse SHARE ACT (HR 1310)
SHARE Act
Client: THE FEDERATION OF STATE MEDICAL BOARDS · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to the licensure of physicians, telemedicine, and state medical boards Issues related to substance abuse SHARE ACT (HR 1310)
Equitable Community Access to Pharmacist Services Act
Client: CENCORA, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Recognizing pharmacists as providers within Medicare; The Equitable Community Access to Pharmacist Services Act (H.R.1770/S. 2477; Medicare reimbursement.
Equitable Community Access to Pharmacist Services Act
Client: CENCORA, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Recognizing pharmacists as providers within Medicare; The Equitable Community Access to Pharmacist Services Act (H.R.1770/S. 2477; Medicare reimbursement.
Equitable Community Access to Pharmacist Services Act
Client: WALGREEN CO. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
H.R. 1770 Equitable community access to pharmacist services act Issues related to drug pricing reform and transparency Issues related to access and distribution of pharmaceutical products Issues related to Artificial Intelligence in healthcare
Equitable Community Access to Pharmacist Services Act
Client: CENCORA, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Recognizing pharmacists as providers within Medicare; The Equitable Community Access to Pharmacist Services Act (H.R.1770/S. 2477; Medicare reimbursement.
Equitable Community Access to Pharmacist Services Act
Client: WALGREEN CO. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
H.R. 1770 Equitable community access to pharmacist services act Issues related to drug pricing reform and transparency Issues related to access and distribution of pharmaceutical products Issues related to Artificial Intelligence in healthcare
Equitable Community Access to Pharmacist Services Act
Client: CENCORA, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Recognizing pharmacists as providers within Medicare; The Equitable Community Access to Pharmacist Services Act (H.R.1770/S. 2477; Medicare reimbursement.
Issues related to funding for emergency nursing. S.1346 Improving Mental Health Access from the Emergency Department Act of 2023 H.R. 7153 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act S. 1514/ H.R. 3172 The HELPER Act Healthcare work shortages H.R.2584/ S.2768 SAVE Act H.R.6960/ S.3765 Reauthorization of the Emergency Medical Services for Children Act
Issues related to funding for emergency nursing S.1346 Improving Mental Health Access from the Emergency Department Act of 2023 H.R. 7153 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act Healthcare work shortages H.R.2584/ S.2768 SAVE Act H.R.6960/ S.3765 Reauthorization of the Emergency Medical Services for Children Act
H.R. 7153 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act Healthcare work shortages H.R.2584/ S.2768 SAVE Act H.R.6960/ S.3765 Reauthorization of the Emergency Medical Services for Children Act
Issues related to funding for emergency nursing S.1346 Improving Mental Health Access from the Emergency Department Act of 2023 H.R. 7153 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act Healthcare work shortages H.R.2584/ S.2768 SAVE Act H.R.6960/ S.3765 Reauthorization of the Emergency Medical Services for Children Act
Medicaid VBPs for Patients Act
Client: SPARK THERAPEUTICS, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to the development of gene therapies for rare diseases S. 4204/ H.R. 2666 MVP ACT
Medicaid VBPs for Patients Act
Client: SPARK THERAPEUTICS, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to the development of gene therapies for rare diseases S. 4204/ H.R. 2666 MVP ACT
Medicaid VBPs for Patients Act
Client: SPARK THERAPEUTICS, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to the development of gene therapies for rare diseases S. 4204/ H.R. 2666 MVP ACT
Vietnam Human Rights Act
Client: EMERGENCY NURSES ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to funding for emergency nursing. S.1346 Improving Mental Health Access from the Emergency Department Act of 2023 H.R. 7153 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act S. 1514/ H.R. 3172 The HELPER Act Healthcare work shortages H.R.2584/ S.2768 SAVE Act H.R.6960/ S.3765 Reauthorization of the Emergency Medical Services for Children Act
NIH Clinical Trial Diversity Act of 2023
Client: UNIVERSITY OF COLORADO HEALTH · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to Medicare coverage and reimbursement and Medicaid coverage and reimbursement H.R. 3503 NIH Clinical Trial Diversity Act of 2023
NIH Clinical Trial Diversity Act of 2023
Client: UNIVERSITY OF COLORADO HEALTH · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to Medicare coverage and reimbursement and Medicaid coverage and reimbursement H.R. 3503 NIH Clinical Trial Diversity Act of 2023
To amend the Public Health Service Act to require the development of a diagnostic testing preparedness plan to be used during public health emergencies, and for other purposes.
Client: CEPHEID · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to diagnostic testing and reimbursement related to COVID testing Issues related to the Strategic National Stockpile, supply chain, and future pandemic preparedness PREVENT Pandemics Act FY 2024 Appropriations PASTEUR ACT/ Issues related to antimicrobial resistance Issues related to adoption of PLA codes Pandemic and All-Hazards Preparedness Act Reauthorization H.R. 3795 To amend the Public Health Service Act Alzheimer's testing Tuberculosis testing
To amend the Public Health Service Act to require the development of a diagnostic testing preparedness plan to be used during public health emergencies, and for other purposes.
Client: CEPHEID · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to diagnostic testing and reimbursement. Issues related to the Strategic National Stockpile, supply chain, and future pandemic preparedness PREVENT Pandemics Act FY 2024 Appropriations PASTEUR ACT/ Issues related to antimicrobial resistance Issues related to adoption of PLA codes Pandemic and All-Hazards Preparedness Act Reauthorization H.R. 3795 To amend the Public Health Service Act Alzheimer's testing issues related to hepatitis-C including HEP-C testing
To amend the Public Health Service Act to require the development of a diagnostic testing preparedness plan to be used during public health emergencies, and for other purposes.
Client: CEPHEID · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to diagnostic testing and reimbursement. Issues related to the Strategic National Stockpile, supply chain, and future pandemic preparedness PREVENT Pandemics Act FY 2024 Appropriations PASTEUR ACT/ Issues related to antimicrobial resistance Issues related to adoption of PLA codes Pandemic and All-Hazards Preparedness Act Reauthorization H.R. 3795 To amend the Public Health Service Act issues related to hepatitis-C including HEP-C testing
Treat and Reduce Obesity Act of 2023
Client: LILLY USA, LLC · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to the pharmaceutical industry Issues related to Inflation Reduction Act Implementation H.R. 4818 Treat and Reduce Obesity Act
Treat and Reduce Obesity Act of 2023
Client: LILLY USA, LLC · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to the pharmaceutical industry Issues related to Inflation Reduction Act Implementation H.R. 4818 Treat and Reduce Obesity Act
Treat and Reduce Obesity Act of 2023
Client: LILLY USA, LLC · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to the pharmaceutical industry Issues related to Inflation Reduction Act Implementation H.R. 4818 Treat and Reduce Obesity Act
BECTON, DICKINSON AND COMPANY via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · third_quarter · Q3
Issues related to medical device reimbursement.
Issues related medical technology regulation.
Filing targets: State, Dept of (DOS)
STATE COLLECTION SERVICE, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · third_quarter · Q3
Issues related to debt collection, loan servicing, and medical debt. Regulation of making phone calls in relation to debt collection
Filing targets: Consumer Financial Protection Bureau (CFPB), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SKILLFUL COMMUNICATIONS, INC. DBA BIG INTERVIEW via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · third_quarter · Q3
Legislation and funding opportunities impacting workforce development.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
MODERNA US INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · third_quarter · Q3
Issues related to drug discovery, drug development, vaccine technologies, and coverage and reimbursement Issues related to biotechnology legislation and supply chain
Filing targets: HOUSE OF REPRESENTATIVES, Office of Policy Development
TOLMAR, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · third_quarter · Q3
Advocacy around issues affecting the pharmaceutical industry, such as the Medicare Drug Price Negotiation Program under the Inflation Reduction Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVARTIS via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · third_quarter · Q3
Issues related to cell and gene therapy and radioligand therapies Pharmaceutical pricing Issues related to the development of therapies for rare diseases 340B Drug Discount Program Supply chain issues affecting pharmaceutical products Implementation of the Inflation reduction Act Pharmaceutical innovation PBM policy issues HR 1672 The Maintaining Investments in New Innovations (MINI) Act Intellectual property Issues Tariff issues affecting the pharmaceutical industry EPIC Act Most Favored Nation (MFN) policy Tribal health issues
Filing targets: Indian Health Service, SENATE
SOLVD HEALTH via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · first_quarter · 1A
Issues related to diagnostic tests Medicare, Medicaid coverage and reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
SOLVD HEALTH via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · second_quarter · 2A
Issues related to diagnostic tests Medicare, Medicaid coverage and reimbursement
STATE COLLECTION SERVICE, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · first_quarter · 1A
Issues related to debt collection, loan servicing, and medical debt. Regulation of making phone calls in relation to debt collection
Filing targets: Consumer Financial Protection Bureau (CFPB), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ABBVIE via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · third_quarter · Q3
Issues related to patient access, pharmaceutical manufacturing, Patent reform, and drug pricing both domestic and international Issues realted to medicare drug pricing and reimbursement Direct to Consumer Advertising
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ESO SOLUTIONS, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · third_quarter · Q3
Issues related to data and technology in the EMS space
LIFEPOINT HEALTH via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · third_quarter · Q3
Rural healthcare coverage and reimbursement Student loan repayment Competition issues Healthcare workforce and staffing issues Medicare and Medicaid reimbursement Medicaid provider tax State directed payments Rural Health Transformation Fund H.R.3108/ S.1535 RPM Access Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS (N.A.C.H.)-CHA via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · third_quarter · Q3
General issues of importance to children's hospitals Adovcacy for philanthropic opportunities for children's hospitals Children's healthcare coverage and reimbursement issues Issues related to CHGME Issues related to HHS Funding Medicaid provider tax State directed payments
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
KYVERNA THERAPEUTICS, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · third_quarter · Q3
Outreach regarding cell therapies for autoimmune diseases.
Filing targets: Health & Human Services, Dept of (HHS)
CENTENE CORPORATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · third_quarter · Q3
Issues related to ACA, Medicare Advantage, and Medicaid Issues related to Artificial Intelligence in healthcare issues related to healthcare affordability Regulatory policy related to LTC pharmaceutical services
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JOHNSON & JOHNSON SERVICES, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · third_quarter · Q3
Trade and tariffs affecting the pharmaceutical industry
Issues related to patient access Issues related to patents Legislation related to competition and intellectual property issues in the healthcare space Drug pricing Healthcare workforce issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FERRING PHARMACEUTICALS INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · third_quarter · Q3
Issues related to microbiome, oncology, & fertility Issues related to formulary tier status Drug pricing policy Healthcare policy in the NDAA IVF Tax credit FDA Review programs
Issues related to pharmaceutical tariffs
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
EMERGENCY NURSES ASSOCIATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · third_quarter · Q3
S. 266 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act Healthcare work shortages S.1600 Save Healthcare Workers Act S. 921 Tyler's Law H.R. 2004 Tyler's Law
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELI LILLY AND COMPANY via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · third_quarter · Q3
Issues related to the pharmaceutical industry Treat and Reduce Obesity Act Pharmaceutical tariffs Safe Drugs Act
Issues related to biotechnology legislation Diagnostic tests Clinical trial issues Issues related to supply chain
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EDERA L3C via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · third_quarter · Q3
Healthcare IT issues and Artificial Intelligence Augmenting VA research capacity
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
CONSENSUS CLOUD SOLUTIONS via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · third_quarter · Q3
Issues related to Healthcare, interoperability, digital cloud fax technology, and artificial intelligence
ROMER INSTITUTE OF STROKE AND NEUROLOGY (RISN) via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · third_quarter · Q3
Strategy to establish a CMMI pilot program related to stroke recovery and advocacy around the Stroke Act (S. 5260).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SNAP DIAGNOSTICS, LLP via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · third_quarter · 3T
Issues related to CMS rule making. Issues related to Medicare & Medicaid coverage in regard to sleep technology and digital health innovation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · third_quarter · Q3
Issues related to pharmaceutical manufacturing Tax and trade policy affecting the pharmaceutical industry Drug pricing issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TAPESTRYHEALTH via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · third_quarter · Q3
Issues related to telehealth Telehealth Extension and Evaluation Act Physician coverage and reimbursement issues Remote monitoring Expanding Remote Monitoring Access Act RPM Cost Sharing Elimination Study Act Physician Fee Schedule Remote patient monitoring
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ASANA VOICES via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · third_quarter · Q3
Advancing legislation on cardiovascular health and related issues. S.5469 HEART Foundation Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEXAS CHILDREN'S HOSPITAL via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · third_quarter · Q3
Pediatric health care issues Medicaid coverage and reimbursement Maternal health Pediatric cancer research funding PACT ACT and CHGME Funding Global pediatric healthcare issues State directed payments
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ARDENT HEALTH SERVICES via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · third_quarter · Q3
Medicare coverage and reimbursement issues Medicaid coverage issues Medicaid provider tax State directed payments Price transparency issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE INTERNATIONAL ASSOCIATION OF LIONS CLUBS via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · third_quarter · Q3
Safeguarding U.S. foreign aid for global health initiatives, promoting public health legislation and campaigns. H.R.3674 Global Alzheimers Initiative Now Act H.R.2527 Early Detection of Vision Impairments for Children Issues related to resolution on volunteer service
Filing targets: HOUSE OF REPRESENTATIVES
UNIVERSITY OF COLORADO HEALTH via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · third_quarter · Q3
Issues related to Medicare coverage and reimbursement Issues related to hospital reforms and price transparency Medicaid provider tax issue State directed payments S.2355 - Patients Deserve Price Tags Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VALLEY CHILDREN'S HEALTHCARE via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · third_quarter · Q3
Issues related to Children's Hospitals Graduate Medical Education Payment (CHGME) program Issues related to children's mental health Medicaid coverage and reimbursement issues Pediatric workforce funding FEMA Funding Delays
Filing targets: SENATE
ADVANCING MENTAL HEALTH FOR MILITARY FAMILIES, LLC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · third_quarter · Q3
Advocating for increased access to outpatient mental health care services provided in community settings for veterans, active duty servicemembers, and their families who are in need of treatment for mental health issues (depression, anxiety, and PTSD). Specifically, advocating for enactment of H.R. 2283, the RECOVER Act, which would permit VA to contract with outpatient community providers to deliver evidence-based mental health treatment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE JEWISH FEDERATIONS OF NORTH AMERICA via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · third_quarter · Q3
Anti-Semitism in healthcare Medicare and Medicaid funding, food assistance funding Proposed rulemaking impacting the Jewish community
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), White House Office
ROMER INSTITUTE OF STROKE AND NEUROLOGY (RISN) via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · third_quarter · RR
Strategy to establish a CMMI pilot program related to stroke recovery and advocacy around the Stroke Act (S. 5260).
BECTON, DICKINSON AND COMPANY via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · third_quarter · RR
Issues related to medical technology regulation. Issues related to medical device reimbursement. Medical device supply chain and international trade issues.
Issues related to medical technology regulation. Issues related to medical device reimbursement. Medical device supply chain and international trade issues.
Issues related to medical technology regulation. Issues related to medical device reimbursement. Medical device supply chain and international trade issues.
TOLMAR, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · third_quarter · RR
Advocacy around issues affecting the pharmaceutical industry, such as the Medicare Drug Price Negotiation Program under the Inflation Reduction Act.
ASANA VOICES via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · second_quarter · Q2
Advancing legislation on cardiovascular health and related issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVARTIS via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · second_quarter · Q2
Issues related to cell and gene therapy and radioligand therapies Pharmaceutical pricing Issues related to the development of therapies for rare diseases 340B Drug Discount Program Supply chain issues affecting pharmaceutical products Implementation of the Inflation reduction Act Pharmaceutical innovation PBM policy issues HR 1672 The Maintaining Investments in New Innovations (MINI) Act Intellectual property Issues Tariff issues affecting the pharmaceutical industry EPIC Act Most Favored Nation (MFN) policy
Filing targets: HOUSE OF REPRESENTATIVES, U.S. Trade Representative (USTR)
ABBVIE via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · second_quarter · Q2
Issues related to patient access, pharmaceutical manufacturing, Patent reform, and drug pricing both domestic and international Issues realted to medicare drug pricing and reimbursement DTC Advertising
Filing targets: HOUSE OF REPRESENTATIVES
THE INTERNATIONAL ASSOCIATION OF LIONS CLUBS via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · second_quarter · Q2
Safeguarding U.S. foreign aid for global health initiatives, promoting public health legislation and campaigns.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS)
FERRING PHARMACEUTICALS INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · second_quarter · Q2
Issues related to pharmaceutical tariffs
Issues related to microbiome, oncology, & fertility Issues related to formulary tier status Drug pricing policy Healthcare policy in the NDAA IVF Tax credit FDA Review programs
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ELI LILLY AND COMPANY via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · second_quarter · Q2
Issues related to the pharmaceutical industry Treat and Reduce Obesity Act Pharmaceutical tariffs Safe Drugs Act
Issues related to biotechnology legislation Diagnostic tests Clinical trial issues Issues related to supply chain
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ESO SOLUTIONS, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · second_quarter · Q2
Issues related to data and technology in the EMS space
EMERGENCY NURSES ASSOCIATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · second_quarter · Q2
S. 266 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act Healthcare work shortages S.1600 Save Healthcare Workers Act S. 921 Tyler's Law H.R. 2004 Tyler's Law
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EDERA L3C via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · second_quarter · Q2
Healthcare IT issues and Artificial Intelligence
Filing targets: Defense, Dept of (DOD), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Social Security Administration (SSA), Veterans Affairs, Dept of (VA)
JOHNSON & JOHNSON SERVICES, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · second_quarter · Q2
Trade and tariffs affecting the pharmaceutical industry
Issues related to patient access Issues related to patents Legislation related to competition and intellectual property issues in the healthcare space Drug pricing Healthcare workforce issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Treasury, Dept of
KYVERNA THERAPEUTICS, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · second_quarter · Q2
Outreach regarding cell therapies for autoimmune diseases.
Filing targets: Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), White House Office
LIFEPOINT HEALTH via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · second_quarter · Q2
Rural healthcare coverage and reimbursement Student loan repayment Competition issues Healthcare workforce and staffing issues Medicare and Medicaid reimbursement Medicaid provider tax State directed payments Rural Health Transformation Fund
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MODERNA US INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · second_quarter · Q2
Issues related to drug discovery, drug development, vaccine technologies, and coverage and reimbursement Issues related to biotechnology legislation and supply chain n
Filing targets: White House Office
NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS (N.A.C.H.)-CHA via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · second_quarter · Q2
General issues of importance to children's hospitals Adovcacy for philanthropic opportunities for children's hospitals Children's healthcare coverage and reimbursement issues Issues related to CHGME Issues related to HHS Funding Medicaid provider tax State directed payments
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL MENTOR HOLDINGS, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · second_quarter · Q2
Issues related workforce development, HCBS Funding Medicaid Reimbursement Medicaid coverage for individuals with disabilities and brain injuries
Filing targets: SENATE
CONSENSUS CLOUD SOLUTIONS via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · second_quarter · Q2
Issues related to Healthcare, interoperability, digital cloud fax technology, and artificial intelligence
SKILLFUL COMMUNICATIONS, INC. DBA BIG INTERVIEW via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · second_quarter · Q2
Legislation and funding opportunities impacting workforce development.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
SNAP DIAGNOSTICS, LLP via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · second_quarter · Q2
Issues related to CMS rule making. Issues related to Medicare & Medicaid coverage in regards to sleep technology and digital health innovation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SOLVD HEALTH via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · second_quarter · Q2
Issues related to diagnostic tests Medicare, Medicaid coverage and reimbursement
ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · second_quarter · Q2
Issues related to pharmaceutical manufacturing Tax and trade policy affecting the pharmaceutical industry
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
STATE COLLECTION SERVICE, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · second_quarter · Q2
Issues related to debt collection, loan servicing, and medical debt. Regulation of making phone calls in relation to debt collection
Filing targets: Centers For Medicare and Medicaid Services (CMS), Consumer Financial Protection Bureau (CFPB), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ARDENT HEALTH SERVICES via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · second_quarter · Q2
Medicare coverage and reimbursement issues Medicaid coverage issues Medicaid provider tax State directed payments P.L. 119-21 (H.R. 1): One Big Beautiful Bill implementation
Filing targets: HOUSE OF REPRESENTATIVES
THE JEWISH FEDERATIONS OF NORTH AMERICA via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · second_quarter · Q2
Anti-Semitism in healthcare Medicare and Medicaid funding, food assistance funding
Filing targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), White House Office
RELX INC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · second_quarter · Q2
Healthcare interoperability Scientific research
Filing targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
CENTENE CORPORATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · second_quarter · Q2
Issues related to ACA, Medicare Advantage, and Medicaid Issues related to Artificial Intelligence in healthcare P.L. 119-21 (H.R. 1): One Big Beautiful Bill implementation Healthcare premium tax credits Pharmacy contracts for long term care (LTC)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CENCORA, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · second_quarter · Q2
Recognizing pharmacists as providers within Medicare; The Equitable Introduction of Community Access to Pharmacist Services Act Medicare reimbursement.
Drug Shortages; supply chain resiliency; PAHPA Reauthorization; Drug Supply Chain Security Act (DSCSA) Implementation, SUPPORT Act Reauthorization, Appropriations bills (FDA, Labor, HHS).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ADVANCING MENTAL HEALTH FOR MILITARY FAMILIES, LLC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · second_quarter · Q2
Advocating for increased access to outpatient mental health care services provided in community settings for veterans, active duty servicemembers, and their families who are in need of treatment for mental health issues (depression, anxiety, and PTSD). Specifically, advocating for enactment of H.R. 2283, the RECOVER Act, which would permit VA to contract with outpatient community providers to deliver evidence-based mental health treatment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TAPESTRYHEALTH via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · second_quarter · Q2
Issues related to telehealth Telehealth Extension and Evaluation Act Physician coverage and reimbursement issues Remote monitoring Expanding Remote Monitoring Access Act RPM Cost Sharing Elimination Study Act Physician Fee Schedule
Filing targets: Centers For Medicare and Medicaid Services (CMS)
TEXAS CHILDREN'S HOSPITAL via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · second_quarter · Q2
Pediatric health care issues Medicaid coverage and reimbursement Maternal health Pediatric cancer research funding PACT ACT and CHGME Funding Global pediatric healthcare issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS)
UNIVERSITY OF COLORADO HEALTH via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · second_quarter · Q2
Issues related to Medicare coverage and reimbursement Issues related to hospital reforms and price transparency Medicaid provider tax issue State directed payments
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VALLEY CHILDREN'S HEALTHCARE via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · second_quarter · Q2
Issues related to Children's Hospitals Graduate Medical Education Payment (CHGME) program Issues related to children's mental health Medicaid coverage and reimbursement issues Pediatric workforce funding FEMA Funding Delays H.R. 2106 The Expanding Medical Education Act H.R. 4849 Protecting Health Care and Lowering Costs Act of 2025
Filing targets: SENATE
ASANA VOICES via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · second_quarter · RR
Advancing legislation on cardiovascular health and related issues.
SNAP DIAGNOSTICS, LLP via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · second_quarter · RR
Issues related to CMS rule making. Issues related to Medicare & Medicaid coverage and digital health innovation.
NOVARTIS via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · first_quarter · Q1
Issues related to cell and gene therapy and radioligand therapies Pharmaceutical pricing Issues related to the development of therapies for rare diseases 340B Drug Discount Program Supply chain issues affecting pharmaceutical products Implementation of the Inflation reduction Act Pharmaceutical innovation PBM policy issues HR 1672 The Maintaining Investments in New Innovations (MINI) Act Intellectual property Issues Tariff issues affecting the pharmaceutical industry EPIC Act Most Favored Nation (MFN) policy
Filing targets: U.S. Trade Representative (USTR)
RELX INC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · first_quarter · Q1
Healthcare interoperability Scientific research
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Management & Budget (OMB), SENATE
SOLVD HEALTH via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · first_quarter · Q1
Issues related to diagnostic tests Medicare, Medicaid coverage and reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
EDERA L3C via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · first_quarter · Q1
Healthcare IT issues and Artificial Intelligence
Filing targets: General Services Administration (GSA), Health & Human Services, Dept of (HHS)
CENTENE CORPORATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · first_quarter · Q1
Issues related to ACA, Medicare Advantage, and Medicaid Issues related to Artificial Intelligence in healthcare P.L. 119-21 (H.R. 1): One Big Beautiful Bill implementation Healthcare premium tax credits
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
JOHNSON & JOHNSON SERVICES, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · first_quarter · Q1
Issues related to patient access Issues related to patents Legislation related to competition and intellectual property issues Drug pricing
Trade and tariffs affecting the pharmaceutical industry
Filing targets: HOUSE OF REPRESENTATIVES, Treasury, Dept of
KYVERNA THERAPEUTICS, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · first_quarter · Q1
Outreach regarding cell therapies for autoimmune diseases.
LIFEPOINT HEALTH via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · first_quarter · Q1
Rural healthcare coverage and reimbursement Student loan repayment Competition issues Healthcare workforce and staffing issues Medicare and Medicaid reimbursement Issues related to emergency response for healthcare facilities Medicaid provider tax State directed payments Rural Health Transformation Fund
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELI LILLY AND COMPANY via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · first_quarter · Q1
Issues related to biotechnology legislation Diagnostic tests Clinical trial issues Issues related to supply chain
Issues related to the pharmaceutical industry Issues related to Inflation Reduction Act Implementation Treat and Reduce Obesity Act Pharmaceutical tariffs Safe Drugs Act
Filing targets: Commerce, Dept of (DOC), SENATE
GRINDR LLC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · first_quarter · Q1
HIV prevention, PEPFAR, family formation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS)
FERRING PHARMACEUTICALS INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · first_quarter · Q1
Issues related to microbiome, oncology, & fertility Issues related to formulary tier status Drug pricing policy Healthcare policy in the NDAA IVF Tax credit
Issues related to pharmaceutical tariffs
Filing targets: Bureau of Industry and Security (BIS), Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ESO SOLUTIONS, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · first_quarter · Q1
Issues related to data and technology in the EMS space
Filing targets: Centers For Medicare and Medicaid Services (CMS)
EMERGENCY NURSES ASSOCIATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · first_quarter · Q1
S. 266 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act Healthcare work shortages S.1600 Save Healthcare Workers Act S. 921 Tyler's Law H.R. 2004 Tyler's Law
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MODERNA US INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · first_quarter · Q1
Issues related to drug discovery, drug development, vaccine technologies, and coverage and reimbursement Issues related to biotechnology legislation and supply chain
Filing targets: Executive Office of the President (EOP), Health & Human Services, Dept of (HHS), White House Office
MUSCLESOUND, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · first_quarter · Q1
Issues related to increased access to healthcare technology and malnutrition reimbursement
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS (N.A.C.H.)-CHA via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · first_quarter · Q1
General issues of importance to children's hospitals Children's healthcare coverage and reimbursement issues Issues related to CHGME Issues related to HHS Funding Medicaid provider tax State directed payments
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
STATE COLLECTION SERVICE, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · first_quarter · Q1
Issues related to debt collection, loan servicing, and medical debt. Regulation of making phone calls in relation to debt collection
Filing targets: Consumer Financial Protection Bureau (CFPB), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CLEAR via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · first_quarter · Q1
Issues related to biometric/ identity verification Issues related to transportation and security
THE INTERNATIONAL ASSOCIATION OF LIONS CLUBS via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · first_quarter · Q1
Safeguarding U.S. foreign aid for global health initiatives, promoting public health legislation and campaigns.
ADVANCING MENTAL HEALTH FOR MILITARY FAMILIES, LLC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · first_quarter · Q1
Advocating for increased access to outpatient mental health care services provided in community settings for veterans, active duty servicemembers, and their families who are in need of treatment for mental health issues (depression, anxiety, and PTSD). Specifically, advocating for enactment of H.R. 2283, the RECOVER Act, which would permit VA to contract with outpatient community providers to deliver evidence-based mental health treatment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VALLEY CHILDREN'S HEALTHCARE via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · first_quarter · Q1
Issues related to Children's Hospitals Graduate Medical Education Payment (CHGME) program Issues related to children's mental health Medicaid coverage and reimbursement issues Pediatric workforce funding H.R. 1189 The National Plan for Epilepsy H.R. 2106 The Expanding Medical Education Act H.R. 4849 Protecting Health Care and Lowering Costs Act of 2025
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DEACON HEALTH via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · first_quarter · Q1
Issues related to artificial intelligence, privacy, and technology affecting the healthcare communities and care giving facilities. CMMI Models
CONSENSUS CLOUD SOLUTIONS via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · first_quarter · Q1
Issues related to Healthcare, interoperability, digital cloud fax technology, and artificial intelligence
NATIONAL MENTOR HOLDINGS, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · first_quarter · Q1
Issues related workforce development, HCBS Funding Medicaid Reimbursement Medicaid coverage for individuals with disabilities and brain injuries
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CENCORA, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · first_quarter · Q1
Recognizing pharmacists as providers within Medicare; The Equitable Introduction of Community Access to Pharmacist Services Act Medicare reimbursement.
IRA implementation. Drug Shortages; supply chain resiliency; PAHPA Reauthorization; Drug Supply Chain Security Act (DSCSA) Implementation, SUPPORT Act Reauthorization, Appropriations bills (FDA, Labor, HHS).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ABBVIE via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · first_quarter · Q1
Issues related to patient access, pharmaceutical manufacturing, Patent reform, and drug pricing both domestic and international Issues realted to medicare drug pricing and reimbursement DTC Advertising
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EDERA L3C via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · first_quarter · RR
Healthcare IT issues and AI
PIERRE FABRE PHARMACEUTICALS INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · first_quarter · Q1
Issues related to drug development, rare disease innovations, and issues impacting the pharmaceutical industry.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
ARDENT HEALTH SERVICES via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · first_quarter · Q1
Medicare coverage and reimbursement issues Medicaid coverage issues Medicaid provider tax State directed payments Enhanced premium tax credit P.L. 119-21 (H.R. 1): One Big Beautiful Bill implementation
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SKILLFUL COMMUNICATIONS, INC. DBA BIG INTERVIEW via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2026 · first_quarter · Q1
Legislation and funding opportunities impacting workforce development.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), Office of Personnel Management (OPM), SENATE